ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 4 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBOR CAPITAL ADVISORS, INC. | 34,930 | $1,670,353 | 0.32% |
| WOODSTOCK CORP | 8,060 | $385,429 | 0.04% |
| ST GERMAIN D J CO INC | 300 | $14,346 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 18 | $861 | 0.00% |
External links
This page lists ULTRAGENYX PHARMACEUTICAL IN's shareholders in Q4 2023. To view ULTRAGENYX PHARMACEUTICAL IN's shareholder history, click here.